Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis

首次发布于 2020 年 6 月 4 日

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials

计划入组 50 人 · 首次发布于 2020 年 10 月 8 日

Response to CFTR Modulators in CF Patients Under 18 Years

计划入组 600 人 · 首次发布于 2020 年 3 月 10 日

VXc-0522

tgAAV-CFTR

Cystic fibrosis gene therapy - CFTR-cationic lipid complex

Protein Sciences Corporation

United States

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Sanofi-Aventis Deutschland Gmbh

Sweden

TRIKAFTA Expanded by FDA to Treat Younger Cystic Fibrosis Patients and Additional Mutations

FDA Accepts Vertex's NDA for Next-Gen Cystic Fibrosis Triple Therapy

Recode Therapeutics' RCT-2100 Shows Promise for Cystic Fibrosis Treatment